Tenet Healthcare (THC) traded higher Tuesday as fresh buy-side positioning followed a string of bullish analyst updates that have emphasized Tenet’s 2026 earnings power, aided by its higher-margin ambulatory surgery center platform and ongoing capital returns. The shares are also drawing attention with the next major catalyst close: Tenet is set to report first-quarter 2026 results before the market opens on April 30, 2026, followed by a morning conference call.

The latest bullish framing builds on Tenet’s most recent quarterly results and outlook, where the company pointed to solid operating momentum and issued 2026 guidance ranges for net operating revenues and adjusted EBITDA. In recent weeks, analyst commentary has focused on the durability of procedure volumes, pricing/mix, and Tenet’s ability to translate that into cash flow that supports buybacks and deleveraging.

With earnings approaching, attention is likely to concentrate on same-facility trends, ambulatory case growth, and any update to full-year 2026 expectations. Investors will also watch for signs of margin resilience amid labor and supply-cost pressures, plus continued execution on capital allocation priorities including repurchases.